DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Celgene (NASDAQ: CELG)

116.09 -0.11 (-0.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $116.09 -0.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.50
Previous Close $116.20
Daily Range $114.92 - $116.54
52-Week Range $74.00 - $129.06
Market Cap $92.1B
P/E Ratio 39.79
Dividend (Yield) $0.00 (0.0%)
Volume 2,651,131
Average Daily Volume 5,089,083
Current FY EPS $4.11

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

Large Companies With Fastest Revenue and Earnings Growth in 2015

The Most Loved Biotechs of Big Hedge Funds

Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst B

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst Blog

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

How Celgene Stock Is Breaking All the Rules

Celgene Corp. might look grossly overvalued based on its fundamentals. But a deeper look inside the company shows why the stock remains a compelling buy, despite its monstrous five-year run.

Agios Gains on Fast Track Status for Leukemia Drug AG-120 - Analyst Blog

Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

See More CELG News...

CELG's Top Competitors

CELG $116.09 (-0.09%)
Current stock: CELG
AMGN $163.59 (-0.15%)
Current stock: AMGN
BIIB $398.68 (-0.62%)
Current stock: BIIB
$0.00 (0.00%)
Current stock: